First personalised cancer vaccine cuts risk of disease returning in major trial
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"First personalised cancer vaccine cuts risk of disease returning in major trial" is generating significant coverage in the Business category, with 8 articles from 6 distinct sources tracked by PULSE so far.
Outlets currently covering the story include Yahoo Finance, Yahoo, Bloomberg.com and New Scientist. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 2h ago.
Quick answers
Why is "First personalised cancer vaccine cuts risk of disease returning in major trial" trending?
Because 6 independent news sources published 8 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (12)
- Personalized mRNA vaccine for melanoma cut risk of cancer’s return in late-stage trial NBC News · 11h ago
- Doctors call Moderna, Merck's cancer vaccine data a major advancement CNBC · 11h ago
- Cancer vaccine reduces melanoma from returning by 42%, data shows Yahoo · 11h ago
- Will These Nuances Undo Merck And Moderna's Cancer Vaccine? Investor's Business Daily · 11h ago
- Moderna trims losses as investors digest melanoma vaccine trial data Yahoo Finance · 11h ago
- Personalized mRNA Vaccine Cuts Melanoma Death Or Recurrence Risk 42% Yahoo · 11h ago
- Oncologists Cheer Melanoma Data That Tanked Moderna’s Shares Bloomberg.com · 11h ago
- Moderna’s Stock Just Stumbled. Is It a Buy on the Dip? Yahoo Finance · 11h ago
- Personalised cancer vaccine expected to be approved next year New Scientist · 11h ago
- Moderna stock extends decline after leaked data on melanoma vaccine trial Yahoo Finance · 11h ago
- Pharmalittle: We're reading about a cancer vaccine, an experimental pancreatic cancer drug, and more STAT · 11h ago
- First-of-Its-Kind Vaccine Ushers in New Hope for Cancer Patients The New York Times · 11h ago
Topics
Related trends
Laika’s First PG-13 Film, Brad Bird’s Neo-Noir and an Alzheimer’s Memoir: Animation’s Revolution Isn’t for Kids
2 news sources are covering this Entertainment story right now — PULSE is tracking how fast it spreads.
Nintendo Switch 2 Gets Its First Software-Only Jailbreak, With Help From OpenAI Codex
The Nintendo Switch 2 has received its first software-only jailbreak, opening new avenues for homebrew and game modification.
Vikings-Colts First Injury Report
Coverage tracks the first Week 7 injury report for the Vikings and Colts, focusing on Jordan Mason.
BioWare Becomes First Major Casualty Of Saudi Arabia’s EA Takeover
1 news sources are covering this Technology story right now — PULSE is tracking how fast it spreads.
Ukraine Takes the War Underground—First Footage of Secret Operation VELES Emerges
6 news sources are covering this World story right now — PULSE is tracking how fast it spreads.
First iPhone Duo Unboxing Video Appears Ahead of Friday Launch
20 news sources are covering this Technology story right now — PULSE is tracking how fast it spreads.